Loading
Everything in development, the open problems and what is being done about them, the roadmaps, and what changed on this record.
What is in development for HPV-positive oropharyngeal cancer, drawn from the whole corpus: 14 items. Drugs are grouped by the most advanced trial phase they have reached anywhere; approved treatments sit under standard of care. Technologies are the methods being tested for this cancer, trials are the studies recorded here, and ideas are proposals not yet in a trial.
Which patients can safely have less treatment, and by what test.
Long-term dry mouth, swallowing difficulty and fibrosis in people cured in their fifties.
Whether therapeutic HPV vaccines add to immunotherapy in recurrent disease.
Nothing recorded yet.
Nothing recorded yet.
Also on OnCo: Treatment journeys · Survivorship planner.
HPV vaccination uptake in boys and in countries where the epidemic is beginning.
Dated changes read from the records linked to this cancer: approvals, regulatory steps, reported trials, guideline versions and milestones. Newest first; no date is inferred.
On EdgeAll 16 changes by month →When this page itself was last checked or edited.
HN005: de-escalated arms had worse PFS; control 2-year PFS 98%.
A milestone in how this cancer is treated.
Two-year progression-free survival 96.
A milestone in how this cancer is treated.
A milestone in how this cancer is treated.